Comparison of topical zinc oxide and silver sulfadiazine in burn wounds: An experimental study;Yanık yarası tedavisinde topikal çinko oksit ile gümüş sülfadiazinin karşılaştırılması: Deneysel çalışma

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 18, Issue 5, 2012, Pages 376-383

  Arslan, Kemal ^a   Karahan, Ömer ^a   Okuş, Ahmet ^a   Ünlü, Yaşar ^a   Eryilmaz, Mehmet Ali ^a   Ay, Serden ^a   Sevinç, Bariş ^a  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Partial thickness burn; Silver sulfadiazine; Zinc oxide

Indexed keywords

SULFADIAZINE SILVER; ZINC OXIDE; DERMATOLOGICAL AGENT; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; EPITHELIZATION; EXPERIMENTAL RABBIT; EXPERIMENTAL STUDY; HISTOPATHOLOGY; NONHUMAN; PARTIAL THICKNESS BURN WOUND; SKIN SCAR; SKINFOLD THICKNESS; TOPICAL TREATMENT; WOUND HEALING; ANATOMY AND HISTOLOGY; ANIMAL; BURNS; CHEMICALLY INDUCED; COMPARATIVE STUDY; DERMIS; DRUG EFFECTS; EPIDERMIS; PATHOLOGY; RABBIT; RANDOMIZATION; SCAR; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BURNS; CICATRIX; DERMATOLOGIC AGENTS; DERMIS; EPIDERMIS; RABBITS; RANDOM ALLOCATION; SILVER SULFADIAZINE; WOUND HEALING; ZINC OXIDE;

EID: 84867916776     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: 10.5505/tjtes.2012.45381     Document Type: Article

References (41)

1. Papini RP, Wilson AP, Steer JA, McGrouther DA, Parkhouse N. Wound management in burn centres in the United Kingdom. Br J Surg 1995;82:505-9.
2. Vloemans AF, Soesman AM, Suijker M, Kreis RW, Middelkoop E. A randomised clinical trial comparing a hydrocolloid- derived dressing and glycerol preserved allograft skin in the management of partial thickness burns. Burns 2003;29:702-10.
3. Gilman & Goodman. Pharmacologic basis of therapeutics. 5th ed. New York: McMullin; 1975. p. 930.
4. Warriner R, Burrell R. Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 2005;18:2-12.
5. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007;33:139-48.
6. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-51.
7. Demling RH, Leslie DeSanti MD. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns 2002;28:264-6.
8. Lansdown AB. Silver. 2: Toxicity in mammals and how its products aid wound repair. J Wound Care 2002;11:173-7.
9. Maghsoudi H, Monshizadeh S, Mesgari M. A comparative study of the burn wound healing properties of salinesoaked dressing and silver sulfadiazine in rats. Indian J Surg 2011;73:24-7.
10. Khorasani G, Hosseinimehr SJ, Azadbakht M, Zamani A, Mahdavi MR. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study. Surg Today 2009;39:587-91.
11. Cho Lee AR, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 2005;26:4670-6.
12. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004;30:140-7.
13. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 1996;26:255-60.
14. Sawhney CP, Sharma RK, Rao KR, Kaushish R. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. Burns 1989;15:403-6.
15. Sheridan RL, Petras L, Lydon M, Salvo PM. Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil 1997;18:139-40.
16. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26:131-8.
17. Dickinson SJ. Topical therapy of burns in children with silver sulfadiazine. N Y State J Med 1973;73:2045-9.
18. Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. [Article in French] Ann Dermatol Venereol 2005;132:891-3. [Abstract]
19. Choban PS, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. Am Surg 1987;53:515-7.
20. Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 2007;15:2-16.
21. Prasad AS. Zinc: an overview. Nutrition 1995;11:93-9.
22. Jones PW, Williams DR. The use and role of zinc and its compounds in wound healing. Met Ions Biol Syst 2004;41:139- 83.
23. O'Dell BL. Zinc plays both structural and catalytic roles in metalloproteins. Nutr Rev 1992;50:48-50.
24. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993;73:79-118.
25. Agren MS, Ostenfeld U, Kallehave F, Gong Y, Raffn K, Crawford ME, et al. A randomized, double-blind, placebocontrolled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen 2006;14:526-35.
26. Sum EY, O'Reilly LA, Jonas N, Lindeman GJ, Visvader JE. The LIM domain protein Lmo4 is highly expressed in proliferating mouse epithelial tissues. J Histochem Cytochem 2005;53:475-86.
27. Zhu CH, Ying DJ, Mi JH, Zhang W, Dong SW, Sun JS, et al. The zinc finger protein A20 protects endothelial cells from burns serum injury. Burns 2004;30:127-33.
28. Lansdown AB, Sampson B, Rowe A. Sequential changes in trace metal, metallothionein and calmodulin concentrations in healing skin wounds. J Anat 1999;195:375-86.
29. Savlov ED, Strain WH, Huegin F. Radiozinc studies in experimental wound healing. J Surg Res 1962;2:209-12.
30. Agren MS, Franzén L. Influence of zinc deficiency on breaking strength of 3-week-old skin incisions in the rat. Acta Chir Scand 1990;156:667-70.
31. Keefer KA, Iocono JA, Ehrlich HP. Zinc-containing wound dressings encourage autolytic debridement of dermal burns. Wounds 1998;10:54-8.
32. Lansdown AB. Influence of zinc oxide in the closure of open skin wounds. Int J Cosmet Sci 1993;15:83-5.
33. Apelqvist J, Larsson J, Stenström A. Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of DuoDerm and MeZinc. Br J Dermatol 1990;123:787-92.
34. Gang RK. Adhesive zinc tape in burns: results of a clinical trial. Burns 1980;7:322-5.
35. Kietzmann M. Improvement and retardation of wound healing: effects of pharmacological agents in laboratory animals. Vet Dermatol 1999;10:83-8.
36. Agren MS, Strömberg HE. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide. Scand J Plast Reconstr Surg 1985;19:97-100.
37. Brandrup F, Menné T, Agren MS, Strömberg HE, Holst R, Frisén M. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm Venereol 1990;70:231- 5.
38. Strömberg HE, Agren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 1984;111:461-8.
39. Greenhalgh DG. Wound healing. In: Herndon DN, editor. Total burn care. London: W.B. Saunders; 2002. p 523-95.
40. Fu X, Li X, Cheng B, Chen W, Sheng Z. Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Repair Regen 2005;13:122-30.
41. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.